Analyst firms · Raymond James · CVS
Raymond James CVS price target and rating history
CVS Health Corporation (CVS) · Consumer Staples
Raymond James rates CVS Health Corporation (CVS) Outperform with a $120 price target, as of its latest action on Feb 14, 2022. It has published 3 rating actions on CVS since November 2021, including 0 upgrades and 2 downgrades.
- Current rating
- Outperform
- Price target
- $120
- Median target, all firms
- Too few
- Actions on CVS
- 3
Raymond James price target on CVS
Every Raymond James rating on CVS
- Feb 14, 2022
- Feb 11, 2022
- Nov 4, 2021
Questions about Raymond James and CVS
- What is Raymond James's price target for CVS?
- Raymond James's latest stated price target for CVS Health Corporation (CVS) is $120, from its action on Feb 14, 2022.
- What is Raymond James's rating on CVS?
- Raymond James rates CVS Outperform, a bullish rating, as of Feb 14, 2022.
- When did Raymond James last change its view on CVS?
- On Feb 14, 2022, Raymond James downgrades to Outperform from Strong Buy, price target $115 to $120.
More CVS rating histories
All Raymond James ratingsCVS news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.